10th Asia-Pacific Dermatology Conference
University of Western Australia, Australia
Title: Endovascular Deep Vein Reconstruction improves Leg Ulcer Healing
Biography: Patrik J Tosenovsky,
The aim of this study was to analyze how safe and reliable is iliac vein stenting in patients with non-thrombotic iliac/femoral vein lesions. Prospectively maintained database of 50 consecutive patients was analyzed. Total 53 iliac veins were stented for non-thrombotic lesions (compression of iliac vein) during 2011-2016. Patients suffered from variety of symptoms including intractable swelling (C3), healed ulcers/lipodermatosclerosis (C4), active venous ulcer (C5), venous claudications or a combination of symptoms. Patients’ median age was 72 years (range 22-90); male to female ration 21:29 and median follow up was 8.2 months (range 1 to 36 months). Perioperative mortality was 0%, surgical complication rate in 30 days was 2% (1 stent thrombosed; primary stent patency rate was 96%), 2 patients developed a non-surgical complication during first 30 days. 68% of patients with active leg venous ulcer (C6) healed within 12 weeks post intervention. Non-thrombotic iliac vein lesion stenting is safe and reliable and it might be suitable for selected group of patients with advanced skin changes due to venous hypertension.